Usefulness of Gadobenate Dimeglumine - Enhanced Hepatobiliary Phase MR Imaging on Predicting Histological Grade of Hepatocellular Carcinoma

키워드

참고문헌 (37)

1. Ebara M, "Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies", Radiology, 159, pp.371~377 (1986)
2. Karhunen PJ, "Benign hepatic tumours and tumour like conditions in men", J Clin Pathol, 39, pp.183~188 (1986)
3. McGahan JP, "Hepatic ablation using radiofrequency electrocautery", Invest Radiol, 25, pp.267~270 (1990)
4. Ni Y, "The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-mediaenhanced magnetic resonance imaging, tumor differentiation, and vascularization", Invest Radiol, 28, pp.520~528 (1993)
5. Earls JP, "Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation", Radiology, 201, pp.207~214 (1996)
6. Murakami T, "Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP)", Radiology, 200(1), pp.69~77 (1996)
7. Kirchin MA, "Gadobenate dimeglumine (Gd-BOPTA). An overview", Invest Radiol, 33, pp.798~809 (1998)
8. Spinazzi A, "Predictable and unpredictable adverse reactions to uroangiographic contrast media", Acad Radiol, 3(2), pp.S210~S213 (1996)
9. Yu JS, "Hepatic cavernous hemangioma: sonographic patterns and speed of contrast enhancement on multiphase dynamic MR imaging", AJR Am J Roentgenol, 171, pp.1021~1025 (1998)
10. Vogl TJ, "Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers", AJR Am J Roentgenol, 158, pp.887~892 (1992)
11. Grazioli L, "MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment", J Comput Assist Tomogr, 23(1), pp.S61~S64 (1999)
12. Caudana R, "Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application", Radiology, 199, pp.513~520 (1996)
13. Manfredi R, "Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA)", J Magn Reson Imaging, 9, pp.704~710 (1999)
14. Grazioli L, "Hepatocellular carcinoma: correlation between gadobenate dimeglumineenhanced MRI and pathologic findings", Invest Radiol, 35, pp.25~34 (2000)
15. Spinazzi A, "Multihance clinical pharmacology: biodistribution and MR enhancement of the liver", Acad Radiol, 5(1), pp.S86~S89 (1998)
16. Petersein J, "Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study", Radiology, 215, pp.727~736 (2000)
17. Pirovano G, "Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions", AJR Am J Roentgenol, 175, pp.1111~1120 (2000)
18. Kim YK, "Gadobenate dimeglumineenhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions", Eur Radiol, 14, pp.5~13 (2004)
19. Peterson MS, "Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging", Radiology, 201, pp.337~345 (1996)
20. Vogl TJ, "Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation", Radiology, 205, pp.721~728 (1997)
21. Ebara M, "MR imaging of small hepatocellular carcinoma: effect of intratumoral copper content on signal intensity", Radiology, 180, pp.617~621 (1991)
22. Kitagawa K, "Hepatocellular carcinomas with excessive copper accumulation: CT and MR findings", Radiology, 180, pp.623~628 (1991)
23. Kadoya M, "Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings", Radiology, 183, pp.819~825 (1992)
24. Yamashita Y, "Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings", J Magn Reson Imaging, 4, pp.83~90 (1994)
25. Winter TC, 3rd, "Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation", Radiology, 192, pp.379~387 (1994)
26. Manfredi R, "Gadobenate dimeglumine (BOPTA) enhanced MR imaging: patterns of enhancement in normal liver and cirrhosis", J Magn Reson Imaging, 8, pp.862~867 (1998)
27. Ni Y, "Prolonged positive contrast enhancement with Gd-EOBDTPA in experimental liver tumors: potential value in tissue characterization", J Magn Reson Imaging, 4, pp.355~363 (1994)
28. Hamm B, "Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging", Radiology, 195, pp.785~792 (1995)
29. Schuhmann-Giampieri G, "Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system", Radiology, 183, pp.59~64 (1992)
30. van Montfoort JE, "Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1", J Pharmacol Exp Ther, 290, pp.153~157 (1999)
31. Vogl TJ, "Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA", Radiology, 200, pp.59~67 (1996)
32. Reimer P, "Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging", Eur Radiol, 7, pp.275~280 (1997)
33. Huppertz A, "Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations", Radiology, 234, pp.468~478 (2005)
34. Narita M, "Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma", J Gastroenterol, 44, pp.793~798 (2009)
35. Kitao A, "Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging--correlation with molecular transporters and histopathologic features", Radiology, 256, pp.817~826 (2010)
36. Tsuboyama T, "Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation", Radiology, 255, pp.824~833 (2010)
37. Kim JI, "The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver", Invest Radiol, 43, pp.202~210 (2008)

관련 논문AI추천